Business

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE

Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, announced today that it will release its first quarter 2026 financial results and provide a company update after the market closes on Tuesday, May 5, 2026.

articleCumberland Pharmaceuticals Inc.April 28, 20262/company/cumberland-pharmaceuticals-inc/news/cumberland-pharmaceuticals-to-announce-q1-2026-financial-results-and-company-update
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE

About this update from Cumberland Pharmaceuticals Inc.

[{"type":"text","content":"NASHVILLE, Tenn., April 28, 2026 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, announced today that it will release its first quarter 2026 financial results and provide a company update after the market closes on Tuesday, May 5, 2026.","length":288,"tagName":"p"},{"type":"text","content":"A conference call will be held on May 5 at 4:30 p.m. Eastern Time to discuss the results and update.","length":100,"tagName":"p"},{"type":"text","content":"The link to register is https://register-conf.media-server.com/register/BI31a40566a8cb4846873ec8b25642be3a.","length":107,"tagName":"p"},{"type":"text","content":"Once registered, participants can dial in from their phone using a dial-in and PIN number that will be provided to them. Alternatively, they can choose a "Call Me" option to have the system automatically call them at the start of the conference.","length":260,"tagName":"p"},{"type":"text","content":"A replay of the call will be available for one year and can be accessed via the Investor Relations page of Cumberland's website or by visiting https://edge.media-server.com/mmc/p/rik67g7q.","length":192,"tagName":"p"},{"type":"text","content":"Cumberland Pharmaceuticals is a specialty pharmaceutical company dedicated to providing unique products that improve patient care. The company develops, acquires, and commercializes products for the hospital acute care, gastroenterology and oncology market segments.","length":271,"tagName":"p"},{"type":"text","content":"The company's portfolio of FDA-approved brands includes:","length":60,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Acetadote® (acetylcysteine) injection, for the treatment of acetaminophen poisoning;","length":84,"tagName":"p"}]},{"val":[{"type":"text","content":"Caldolor® (ibuprofen) injection, for the treatment of pain and fever;","length":69,"tagName":"p"}]},{"val":[{"type":"text","content":"Kristalose® (lactulose) for oral solution, a prescription laxative, for the treatment of constipation;","length":102,"tagName":"p"}]},{"val":[{"type":"text","content":"Sancuso® (granisetron) transdermal system, for the prevention of nausea and vomiting in patients receiving certain types of chemotherapy treatment;","length":147,"tagName":"p"}]},{"val":[{"type":"text","content":"Vapri...

More updates from Cumberland Pharmaceuticals Inc.

Pharmaceuticals